Back

Virtual physiological analysis of non-culprit disease in patients with STEMI and multivessel disease: a substudy of the COMPLETE trial

2 September 2024 (14:00 - 14:50)
Organised by: Logo
Congress Presentation Part of: Multivessel disease in acute coronary syndromes ST-Elevation Myocardial Infarction (STEMI) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Paul David Morris

University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
Complete revascularisation versus culprit lesion only PCI in patients with non-ST-elevation myocardial infarction and multivessel disease.
Mr Y. Hung (Hong Kong, HK)
Abstract Slides Video
Presentation thumbnail
Complete vs culprit-lesion-only myocardial revascularization in patients with out-of-hospital cardiac arrest: insights from the multicentric "Lombardia CARe" registry
Doctor L. Raone (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
Impact of microvascular resistance reserve on post-STEMI cardiac remodelling and diastolic function
Doctor T. Tsai (Galway, IE)
Abstract Slides Video
Presentation thumbnail
Real-life impact of complete revascularization of non-ST elevation myocardial infarction during index hospitalization
Doctor C. Carvalho (Viana do Castelo, PT)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of the extent of coronary artery disease in patients with acute transmural myocardial infarction undergoing complete percutaneous revascularization
Doctor L. Canton (Bologna, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Multivessel disease in acute coronary syndromes

The Event

Event poster

ESC Congress 2024

2 September 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Lessons learned from the COMPLETE trial and rationale for COMPLETE II
thumbnail
Congress Presentation
Completeness of revascularization in relation to major cardiovascular events in patients with ST-elevation myocardial infarction and multivessel disease: results from the COMPLETE trial
thumbnail
Congress Presentation
Should everyone receive complete revascularisation after primary PCI?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources